Vasgene Therapeutics, Inc is a biotechnology company dedicated to developing innovative gene therapy treatments for a variety of diseases. With a focus on precision medicine, we aim to provide personalized gene-based therapies to improve patient outcomes. Our team of scientists and researchers are committed to advancing the field of gene therapy and revolutionizing healthcare. Visit our website to learn more about our cutting-edge technologies and groundbreaking research.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#219 in Los Angeles, CA

#7,735 in California

#32,588 in US

Los Angeles, CA, United States of America

Vasgene Therapeutics, Inc

Forward Citations = 19

8 inventors:

Valery Krasnoperov (8 out of 10 patents)

Parkash S Gill (8 out of 16 patents)

Ramachandra Reddy (7 out of 8 patents)

4. Sergey Zozulya (6 out of 84 patents)

5. Nathalie Kertesz (6 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vasgene Therapeutics, Inc. Retrieved from https://idiyas.com/company/vasgene-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]